Concepedia

Santo Previti

SP

22

Publications

509

Citations

15

H-Index

2015

Active since

Affiliations

University of Messina(Current)

Johannes Gutenberg University Mainz

University of Campania "Luigi Vanvitelli"

Université de Montpellier

Centre National de la Recherche Scientifique

Santo Previti is an author at University of Messina specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

2015–2024

22

Publications

22

Development of Novel Peptide-Based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs)

Santo Previti, Roberta Ettari, Sandro Cosconati et al. · Journal of Medicinal Chemistry · 2017 · 58 citations · Full text

Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening

Giorgio Amendola, Roberta Ettari, Santo Previti et al. · Journal of Chemical Information and Modeling · 2021 · 54 citations

Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation

Roberta Ettari, Andrea Pinto, Santo Previti et al. · Bioorganic & Medicinal Chemistry · 2015 · 30 citations · Full text

, , +9

Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors

Roberta Ettari, Santo Previti, Sandro Cosconati et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2015 · 29 citations · Full text

, , +15

Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents

Roberta Ettari, Santo Previti, Sandro Cosconati et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 28 citations · Full text

, , +3

Rows per page

1–5 of 22